Tromethamine
FDA-approved product (solution, injection), marketed as Tham, Tromethamine.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 0 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBL- WHO therapeutic group
- Solutions affecting the electrolyte balance; Other i.v. solution additives
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
No supported pathogen reaches ≥40% AI-predicted activity for Tromethamine, so it is not among the repurposing candidates. Its predictions are shown below.
AI-predicted activity
AI prediction · nothing measured- MRSA7.3% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- E. coli8.0% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae4.2% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis9.7% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Tromethamine with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- EverolimusExisting use: Adenoma sebaceum, Anaplastic astrocytoma, Angiomyolipoma and 18 more53.9% AI-predicted activityagainst E. coli50+ registered studies
- UbrogepantExisting use: Migraine disorder53.8% AI-predicted activityagainst E. coli24 registered studies
- Caspofungin AcetateExisting use: Aspergillosis, Candidemia, Candidiasis and 1 more53.7% AI-predicted activityagainst E. coli50+ registered studies
- OdevixibatExisting use: Intrahepatic cholestasis53.7% AI-predicted activityagainst E. coli13 registered studies
- PosaconazoleExisting use: Aspergillosis, Candidiasis, Coccidioidomycosis and 2 more53.6% AI-predicted activityagainst E. coli50+ registered studies
- SiponimodExisting use: Multiple sclerosis53.6% AI-predicted activityagainst E. coli33 registered studies
- LonafarnibExisting use: Hutchinson-Gilford progeria syndrome, Laminopathies, Progeria53.6% AI-predicted activityagainst E. coli39 registered studies
- Brilliant Blue GExisting use: Disclosing Agent53.4% AI-predicted activityagainst E. coli10 registered studies
- AbarelixExisting use: Neoplasm53.4% AI-predicted activityagainst E. coli5 registered studies
- CyclosporineExisting use: Conjunctivitis, Corneal disease, Eye disease and 6 more53.3% AI-predicted activityagainst E. coli50+ registered studies
- Simeprevir SodiumExisting use: Chronic hepatitis C virus infection53.2% AI-predicted activityagainst E. coliNo documented evidence found
- Ergotamine TartrateExisting use: Headache, Migraine disorder53.1% AI-predicted activityagainst E. coli10 registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Anesthetics and Analgesics in Children
NCT03427736 · start 2018-12-13
Registered record
- Registry ID
- NCT03427736
- Conditions
- Anesthesia; Pain
- Interventions
- Ketorolac Tromethamine; Hydromorphone; Ketamine; Oxycodone; Morphine
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Recruiting
- Start
- 2018-12-13
- Completion
- 2027-09-09
- Enrolment
- 551
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAnesthesia; PainInterventionKetorolac Tromethamine; Hydromorphone; Ketamine; Oxycodone +1 morePhaseNot recordedRegistry statusRecruitingComparison of Drugs on Headache Treatment After ECT Treatment
NCT03830398 · start 2018-11-20
Registered record
- Registry ID
- NCT03830398
- Conditions
- Mental Disorders
- Interventions
- Paracetamol; Deksketoprofen trometamol; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Unknown
- Start
- 2018-11-20
- Completion
- 2019-06
- Enrolment
- 225
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMental DisordersInterventionParacetamol; Deksketoprofen trometamol; PlaceboPhasePhase 4Registry statusUnknownRelieving Acute Pain (RAP) Study: A Pilot Study
NCT03426137 · start 2018-09-17
Registered record
- Registry ID
- NCT03426137
- Conditions
- Trauma; Opioid Use; Spine Fusion
- Interventions
- Oxycodone; Ketorolac; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Terminated
- Start
- 2018-09-17
- Completion
- 2020-01-21
- Enrolment
- 3
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionTrauma; Opioid Use; Spine FusionInterventionOxycodone; Ketorolac; PlaceboPhasePhase 2Registry statusTerminatedA Phase I Clinical Study Trial of Felbinac Trometamol Injection in China
NCT03617510 · start 2018-07-10
Registered record
- Registry ID
- NCT03617510
- Conditions
- Pain
- Interventions
- Felbinac Trometamol Injection; Placebos
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Completed
- Start
- 2018-07-10
- Completion
- 2019-04-30
- Enrolment
- 48
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPainInterventionFelbinac Trometamol Injection; PlacebosPhasePhase 1Registry statusCompletedOral Tramadol Versus Oral Dexketoprofen for Reducing Pain During Office Hysteroscopy
NCT03585036 · start 2018-07
Registered record
- Registry ID
- NCT03585036
- Conditions
- Hysteroscopy
- Interventions
- dexketoprofen; Tramadol; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Unknown
- Start
- 2018-07
- Completion
- 2018-10
- Enrolment
- 210
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHysteroscopyInterventiondexketoprofen; Tramadol; PlaceboPhasePhase 3Registry statusUnknownWound Infiltration With Ketorolac Versus Lidocaine for Postoperative Analgesia After Total Abdominal Hysterectomy
NCT03394001 · start 2018-01-01
Registered record
- Registry ID
- NCT03394001
- Conditions
- Anesthesia
- Interventions
- Wound infiltration; Lidocaine Hydrochloride; Ketorolac tromethamine
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Unknown
- Start
- 2018-01-01
- Completion
- 2018-06
- Enrolment
- 80
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAnesthesiaInterventionWound infiltration; Lidocaine Hydrochloride; Ketorolac tromethaminePhasePhase 4Registry statusUnknownStudy of Ketorolac Versus Opioid for Pain After Endoscopy
NCT03888144 · start 2017-10-13
Registered record
- Registry ID
- NCT03888144
- Conditions
- Kidney Calculi; Ureteral Calculi
- Interventions
- Oxycodone; Ketorolac
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2017-10-13
- Completion
- 2021-08-01
- Enrolment
- 81
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionKidney Calculi; Ureteral CalculiInterventionOxycodone; KetorolacPhasePhase 4Registry statusCompletedImpact of Preemptive Intravenous Ibuprofen on Postoperative Edema and Trismus in the Third Molar Teeth
NCT03170713 · start 2017-05-15
Registered record
- Registry ID
- NCT03170713
- Conditions
- Trismus; Edema
- Interventions
- arveles; intrafen; placebos
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2017-05-15
- Completion
- 2017-11-15
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionTrismus; EdemaInterventionarveles; intrafen; placebosPhaseNot applicableRegistry statusUnknownMultimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery
NCT02958566 · start 2017-01
Registered record
- Registry ID
- NCT02958566
- Conditions
- Colon Cancer; Colon Diverticulosis; Colonic Neoplasms; Colonic Diverticulitis; Pain, Postoperative; Ileus; Ileus Paralytic; Ileus; Mechanical; Constipation Drug Induced; Constipation; Rectum Cancer; Rectum Neoplasm
- Interventions
- Acetaminophen; Gabapentin; Orphenadrine; Lidocaine; Marcaine; Ketamine; Methadone; Tramadol; Ketorolac; Morphine Sulfate; Fentanyl; Dilaudid; Hydrocodone-Acetaminophen Tab 5-325 MG; Morphine Sulfate; Fentanyl; Dilaudid; HYDROCODONE/ACETAMINOPHEN 5 Mg-325 Mg ORAL TABLET
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Unknown
- Start
- 2017-01
- Completion
- 2018-12
- Enrolment
- 80
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionColon Cancer; Colon Diverticulosis; Colonic Neoplasms; Colonic Diverticulitis +9 moreInterventionAcetaminophen; Gabapentin; Orphenadrine; Lidocaine +13 morePhasePhase 4Registry statusUnknownDextromethorphan Use in Multimodal Analgesia Regimens for Total Knee Arthroplasty
NCT02987920 · start 2017-01
Registered record
- Registry ID
- NCT02987920
- Conditions
- Pain, Postoperative
- Interventions
- Dextromethorphan; Placebo - Concentrate; Acetaminophen; Oxycodone; Celecoxib; Pantoprazole; Ketorolac; Gabapentin; Hydromorphone
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Terminated
- Start
- 2017-01
- Completion
- 2018-01
- Enrolment
- 23
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPain, PostoperativeInterventionDextromethorphan; Placebo - Concentrate; Acetaminophen; Oxycodone +5 morePhasePhase 4Registry statusTerminatedStatus Migrainosus - Differentiating Between Responders and Non-responders
NCT03066544 · start 2016-11-30
Registered record
- Registry ID
- NCT03066544
- Conditions
- Migraine
- Interventions
- Bupivacaine; Naratriptan Pill; Dexamethasone; Ketorolac
- Study type
- INTERVENTIONAL
- Phase
- Phase 1 / Phase 2
- Registry status
- Unknown
- Start
- 2016-11-30
- Completion
- 2020-06-30
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMigraineInterventionBupivacaine; Naratriptan Pill; Dexamethasone; KetorolacPhasePhase 1 / Phase 2Registry statusUnknownMultimodal Pain Management for Cesarean Delivery
NCT02922985 · start 2016-10
Registered record
- Registry ID
- NCT02922985
- Conditions
- Pain
- Interventions
- Intravenous acetominophen; Ketorolac, intramuscular; Bupivacaine, subcutaneous; Normal saline
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2016-10
- Completion
- 2017-07
- Enrolment
- 120
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPainInterventionIntravenous acetominophen; Ketorolac, intramuscular; Bupivacaine, subcutaneous; Normal salinePhasePhase 4Registry statusCompletedPremedication Efficacy of Ketorolac Infiltration on Post Endodontic Pain
NCT02923687 · start 2016-09
Registered record
- Registry ID
- NCT02923687
- Conditions
- Irreversible Pulpitis
- Interventions
- Ketorolac Tromethamine; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2016-09
- Completion
- 2017-06
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionIrreversible PulpitisInterventionKetorolac Tromethamine; PlaceboPhasePhase 2Registry statusCompletedSafety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years
NCT02787109 · start 2016-07
Registered record
- Registry ID
- NCT02787109
- Conditions
- Chlamydia Trachomatis
- Interventions
- CTH522-CAF01; CTH522-Al(OH)3; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Completed
- Start
- 2016-07
- Completion
- 2017-07-31
- Enrolment
- 35
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChlamydia TrachomatisInterventionCTH522-CAF01; CTH522-Al(OH)3; PlaceboPhasePhase 1Registry statusCompletedAuricular Acupuncture vs SOC in Migraine HA
NCT02681211 · start 2016-02
Registered record
- Registry ID
- NCT02681211
- Conditions
- Migraine Headache
- Interventions
- Auricular Acupuncture; Ketorolac 0.5mg/kg, max 30mg; Metoclopramide 0.1 mg/kg, max 10mg; Diphenhydramine 1mg/kg, max 50mg; Normal saline fluid bolus 20mL/kg, max 1000mL
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2016-02
- Completion
- 2024-11
- Enrolment
- 80
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMigraine HeadacheInterventionAuricular Acupuncture; Ketorolac 0.5mg/kg, max 30mg; Metoclopramide 0.1 mg/kg, max 10mg; Diphenhydramine 1mg/kg, max 50mg +1 morePhaseNot applicableRegistry statusUnknown